equitybuy

BCPC

Trust-weighted public proof page for BCPC. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
27 / 100
Current score
0.46
Thesis calls
1
Active ticker theses
1

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Anecdotal social post claims higher-dose Vitamin K2 (MK-4) plus Vitamin E (mixed tocopherols) improved testosterone/LH dynamics, with commentary that high LH can indicate reduced Leydig-cell sensitivity and oxidative stress/circadian factors. This is not investable as a catalyst by itself, but it loosely reinforces an existing supplement/ingredients demand narrative (fat-soluble vitamins, antioxidant positioning).

Mentioned: Jul 22, 2026, 3:21 PM EDTConviction: 46 / 100Observed price: $162.10 on 2026-07-22Return: -8.66%
Source: _aestheticprimal_ @aestheticprimal Jul 22 I've witnessed interesting reductions in LH whereas Testosterone shot up fr...

Current stance

Recommendationbuy
Authors1
Active ticker theses1
Latest pricen/a
Why now
  • beneficiary via Incremental tailwind for vitamin-ingredient suppliers from renewed social attention to Vitamin K2 + Vitamin E supplementation from https://x.com/aestheticprimal (confidence 0.46)

Unlock full asset monitoring

Create an account to access full asset history, alerts, Telegram workflows, and trust-weighted live rankings across authors, ticker theses, and market events.